US FDA orders post-market studies for needleless connectors
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has written to nine companies manufacturing positive displacement needleless connectors asking them to conduct post-market studies to assess whether their products are associated with a higher rate of device-associated bloodstream infections when compared with other types of needleless connectors.